Nestlé Health Science and IdB Holding have signed a licensing agreement to seek EMA approval for VOWST, the only FDA-approved oral live biotherapeutic for recurrent C. diff prevention
Nestle Health Science is a Switzerland-based pharmaceutical firm that supplies products such as nutritional therapies and meal replacements for the healthcare sector.